Few data are available on the association between a different entity of platelet inhibition on antiplatelet treatment and clinical outcomes in patients with peripheral artery disease (PAD). The aim of this study was to evaluate the degree of on-treatment platelet reactivity, and its association with ischaemic and haemorrhagic adverse events at follow up in PAD patients undergoing percutaneous transluminal angioplasty (PTA).
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty / Grifoni, Elisa; Gori, Anna Maria; Giusti, Betti; Valenti, Renato; Migliorini, Angela; Basili, Stefania; Paniccia, Rita; Elmahdy, Mahmoud Farouk; Pulli, Raffaele; Pratesi, Carlo; Antoniucci, David; Violi, Francesco; Marcucci, Rossella. - In: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. - ISSN 1078-5884. - ELETTRONICO. - (2018), pp. 0-0. [10.1016/j.ejvs.2018.06.032]
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty
Grifoni, Elisa;Gori, Anna Maria;Giusti, Betti;Valenti, Renato;Paniccia, Rita;Pulli, Raffaele;Pratesi, Carlo;Marcucci, Rossella
2018
Abstract
Few data are available on the association between a different entity of platelet inhibition on antiplatelet treatment and clinical outcomes in patients with peripheral artery disease (PAD). The aim of this study was to evaluate the degree of on-treatment platelet reactivity, and its association with ischaemic and haemorrhagic adverse events at follow up in PAD patients undergoing percutaneous transluminal angioplasty (PTA).
| File | Dimensione | Formato | |
|---|---|---|---|
|
Grifoni 2018.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
570.24 kB
Formato
Adobe PDF
|
570.24 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
